Showing results (151-160 of 159) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
Nature Communications|August 8, 2022
Unified classification and risk-stratification in Acute Myeloid LeukemiaYanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.Blood|November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18Steven Knapper, Laura W Dillon, Malavika Babu, et al.Blood|December 12, 2022
Overlapping features of therapy-related and de novo NPM1-mutated AMLJad Othman, Manja Meggendorfer, Enrico Tiacci, et al.Leukemia|February 9, 2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemiaRabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng, et al.Trials|September 6, 2022
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials unitsSharon B Love, Fay Cafferty, Claire Snowdon, et al.Blood Advances|May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First RelapseNiek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.Leukemia|January 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY studyAlberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng, et al.Blood Cancer Discovery|July 3, 2025
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease StatesCurtis A Lachowiez, Georgios Asimomitis, Elsa Bernard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Risk Stratification in Older Intensively Treated Patients With AMLJurjen Versluis, Marlen Metzner, Ariel Wang, et al.Pageof 16